Jane Street’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-35,452
| Closed | -$340K | – | 6979 |
|
|
2024
Q4 | $340K | Sell |
35,452
-67,975
| -66% | -$653K | ﹤0.01% | 4482 |
|
|
2024
Q3 | $296K | Sell |
103,427
-5,663
| -5% | -$16.2K | ﹤0.01% | 4872 |
|
|
2024
Q2 | $319K | Sell |
109,090
-220,830
| -67% | -$645K | ﹤0.01% | 4964 |
|
|
2024
Q1 | $1.05M | Buy |
329,920
+300,437
| +1,019% | +$958K | ﹤0.01% | 3145 |
|
|
2023
Q4 | $99.1K | Buy |
+29,483
| New | +$99.1K | ﹤0.01% | 5263 |
|
|
2023
Q2 | – | Sell |
-253,169
| Closed | -$780K | – | 6122 |
|
|
2023
Q1 | $780K | Buy |
253,169
+182,816
| +260% | +$563K | ﹤0.01% | 3132 |
|
|
2022
Q4 | $373K | Buy |
+70,353
| New | +$373K | ﹤0.01% | 3729 |
|
|
2021
Q3 | – | Sell |
-10,110
| Closed | -$101K | – | 6060 |
|
|
2021
Q2 | $101K | Buy |
+10,110
| New | +$101K | ﹤0.01% | 4743 |
|